Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase             <scp>III</scp>            trial            <scp>FIRE</scp>            ‐3 (            <scp>AIO KRK</scp>            ‐0306)

User: Guest

Title:: Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE ‐3 ( AIO KRK ‐0306)
Document type:: Zeitschriftenaufsatz
Author(s):: Liu, Lian; Erickson, Nicole Tonya; Ricard, Ingrid; Weikersthal, Ludwig Fischer; Lerch, Markus M.; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Höffkes, Heinz‐Gert; Moehler, Markus; Gesenhues, Alena Britta; Theurich, Sebastian; Michl, Marlies; Modest, Dominik P.; Algül, Hana; Stintzing, Sebastian; Heinemann, Volker; Holch, Julian W.
Journal title:: International Journal of Cancer
Year:: 2021
Journal volume:: 150
Journal issue:: 1
Pages contribution:: 112-123
Fulltext / DOI:: doi:10.1002/ijc.33775
Publisher:: Wiley
E-ISSN:: 0020-7136; 1097-0215
Date of publication:: 06.09.2021
BibTeX

Occurrences:

Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first‐line treatment within the randomized Phase III trial FIRE ‐3 ( AIO KRK ‐0306)